See also this year's filing and all EDGAR filings for this company.
PDF Report 0001087294_2015_Cumberland_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001087294, Cumberland Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 70,814,971 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 21,568,541 |
| 2 | PropertyPlantAndEquipmentNet | 651,030 |
| 3 | remainder_Assets | 2,370,572 |
| 4 | LiabilitiesCurrent | 13,749,482 |
| 5 | LiabilitiesNoncurrent | 902,841 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 8,419,304 |
| 9 | ResearchAndDevelopmentExpense | 3,455,830 |
| 10 | remainder_Expenses | 22,727,439 |
| 11 | remainder_Revenues | 36,646,351 |
| 12 | remainder_NetIncome | 256,442 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 95,405,114 |
| 1 | Liabilities | 14,652,323 |
| 2 | Expenses | 34,602,573 |
| 3 | Revenues | 36,646,351 |
| 4 | StockholdersEquity | 80,752,791 |
| 5 | NetIncome | 2,300,220 |
| 6 | ComprehensiveNetIncome | 2,300,220 |
| 7 | BaseVar | 90,781,402 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.24 |
| 9 | EconomicCapitalRatio | 3.85 |
Edgar->Model Mapping
Feature Distribution
Change over Time
